Dudediligence.

Ensysce Biosciences, Inc

ENSCNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Charter or bylaws changeSep 29 →InsidersNo open-market buys or sales.→HoldersJane Street 1.3%Adage Capital Partners GP 0.9%Perceptive 0.5%→Financing →PeersClosest companies: PLYX, CING, DYN→

From the filings

Figures

Revenue
$4.5Mlast 12 months
Net income
−$12.6Mlast 12 months
Operating cash flow
−$9.6Mlast 12 months
Cash and equivalents
$676,704at the last balance sheet
Shares outstanding
16.2M shareson issue
Every year and quarter →